Figure 1: Neuroimaging of two patients with idiopathic normal pressure hydrocephalus. Because INPH is a disease of the elderly population, an age-group in which gait difficulties, dementia ...

CereVasc has reported positive initial results in a pilot study of its eShunt System implant in treating elderly patients with normal pressure hydrocephalus (NPH). At the 90-day primary endpoint of ...

CereVasc, Inc. announced the initial results of its United States pilot clinical study of the CereVasc eShunt system in the ...